509.75
+20.85
+(4.26%)
At close: 3:29:56 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
12,596,500
12,383,900
13,791,900
12,305,500
15,757,300
Cost of Revenue
7,017,900
8,385,100
8,132,200
6,813,200
7,538,500
Gross Profit
5,578,600
3,998,800
5,659,700
5,492,300
8,218,800
Operating Expense
4,869,600
5,979,600
5,328,100
5,790,600
5,391,600
Operating Income
709,000
-1,980,800
331,600
-298,300
2,827,200
Net Non Operating Interest Income Expense
-1,126,200
-1,013,500
-808,600
-623,800
-701,600
Pretax Income
-1,640,200
-4,884,200
-448,200
-911,000
2,215,000
Tax Provision
887,900
785,400
-225,700
-328,100
1,500
Net Income Common Stockholders
-2,527,000
-5,673,900
-221,800
-581,500
2,214,000
Diluted NI Available to Com Stockholders
-2,527,000
-5,673,900
-221,800
-581,500
2,214,000
Basic EPS
-225.74
-145.27
-5.68
-14.91
63.59
Diluted EPS
-225.74
-145.27
-5.68
-14.91
59.47
Basic Average Shares
48,053.02
39,056.74
39,056.74
38,996.58
34,815.79
Diluted Average Shares
48,053.02
39,056.85
39,056.94
38,998.04
37,229.04
Rent Expense Supplemental
--
27,600
12,900
24,900
29,700
Total Expenses
11,887,500
14,364,700
13,460,300
12,603,800
12,930,100
Net Income from Continuing & Discontinued Operation
-2,527,000
-5,673,900
-221,800
-581,500
2,214,000
Normalized Income
-1,677,410
-4,348,380
-224,530
-557,185.84
2,191,315.37
Interest Income
--
22,200
57,800
77,600
142,200
Interest Expense
1,097,900
985,200
833,800
672,800
802,400
Net Interest Income
-1,126,200
-1,013,500
-808,600
-623,800
-701,600
EBIT
-542,300
-3,899,000
385,600
-238,200
3,017,400
EBITDA
459,700
-2,865,700
1,497,500
885,000
4,104,000
Reconciled Cost of Revenue
7,017,900
8,385,100
8,132,200
6,813,200
7,538,500
Reconciled Depreciation
1,002,000
1,033,300
1,111,900
1,123,200
1,086,600
Net Income from Continuing Operation Net Minority Interest
-2,527,000
-5,673,900
-221,800
-581,500
2,214,000
Total Unusual Items Excluding Goodwill
-1,213,700
-1,893,600
3,900
-38,000
22,700
Total Unusual Items
-1,213,700
-1,893,600
3,900
-38,000
22,700
Normalized EBITDA
1,673,400
-972,100
1,493,600
923,000
4,081,300
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-364,110
-568,080
1,170
-13,685.84
15.37
3/31/2021 - 6/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BAJAJHCARE.BO Bajaj HealthCare Limited
579.15
+2.89%
WINDLAS.BO Windlas Biotech Limited
966.75
+8.32%
AMRUTANJAN.NS Amrutanjan Health Care Limited
632.05
-0.61%
GUFICBIO.NS Gufic Biosciences Limited
329.60
+6.39%
WINDLAS.NS Windlas Biotech Limited
967.05
+8.38%
RPGLIFE.NS RPG Life Sciences Limited
2,063.95
+4.80%
IPCALAB.NS Ipca Laboratories Limited
1,330.95
+2.79%
LAURUSLABS.BO Laurus Labs Limited
606.10
+7.58%
AARTIPHARM.NS Aarti Pharmalabs Limited
679.40
+8.81%
IOLCP.NS IOL Chemicals and Pharmaceuticals Limited
61.65
+3.88%